Cipar1/PARM-1 Polyclonal Antibody
Product Specifications
Background
Cipar1 may be involved in a survival program enabling certain prostatic cells to resist apoptosis. It is expressed in prostate and detected in other organs at low levels, these include the heart and various tissues of the urogenital tract; not detected in mammary gland.
Synonyms
Alternative namesCastration induced prostatic apoptosis related protein 1; Cipar 1; Cipar-1; Prostatic androgen repressed message 1 protein; Protein PARM 1 Precursor; PARM1_HUMAN.
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Immunogen
201-310/310
Target
Cipar1/PARM-1
Clonality
Polyclonal
Isotype
IgG
Conjugation
Unconjugated
Source
KLH conjugated synthetic peptide derived from human Cipar1
Applications
ELISA, IHC-P, IHC-F, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Concentration
1µg/µl
Dilution
ELISA (1:500-1000), IHC-P (1:200-400), IHC-F (1:100-500), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Predicted Cross Reactivity
Human
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62603R-BF555-01 20 µL
FRAT1 Recombinant Antibody, AbBy Fluor™ 555 Conjugated
Sign In for Pricing
View Details bsm-62603R-BF555-02 100 µL
FRAT1 Recombinant Antibody, AbBy Fluor™ 555 Conjugated
Sign In for Pricing
View Details 